-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
5 Value Stocks To Watch In The Healthcare Sector
5 Value Stocks To Watch In The Healthcare Sector
What are Value Stocks?
A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued.
Benzinga Insights has compiled a list of value stocks in the healthcare sector that may be worth watching:
- Vicarious Surgical (NYSE:RBOT) - P/E: 6.22
- Walgreens Boots Alliance (NASDAQ:WBA) - P/E: 8.07
- Pfizer (NYSE:PFE) - P/E: 9.91
- Aadi Bioscience (NASDAQ:AADI) - P/E: 2.79
- Innoviva (NASDAQ:INVA) - P/E: 4.04
Vicarious Surgical's earnings per share for Q3 sits at $-0.18, whereas in Q2, they were at -0.16. Most recently, Walgreens Boots Alliance reported earnings per share at $0.8, whereas in Q3 earnings per share sat at $0.96. Its most recent dividend yield is at 5.41%, which has increased by 0.35% from 5.06% in the previous quarter.
Pfizer has reported Q3 earnings per share at $1.78, which has decreased by 12.75% compared to Q2, which was 2.04. Most recently, the company reported a dividend yield of 3.17%, which has decreased by 0.47% from last quarter's yield of 3.64%.
Aadi Bioscience saw an increase in earnings per share from -0.69 in Q2 to $-0.68 now. Most recently, Innoviva reported earnings per share at $2.8, whereas in Q2 earnings per share sat at $0.05.
These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.
What are Value Stocks?
什麼是價值股?
A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued.
與同行業公司的股票價格相比,價值股票的價格通常較低。這表明該公司的價值可能被低估,因為投資者並沒有對此類公司表達盡可能多的興趣。檢查價值的最常用方法是使用價格對盈利倍數或市盈率(P/E 倍數)。低 P/E 倍數表明股票價值被低估。
Benzinga Insights has compiled a list of value stocks in the healthcare sector that may be worth watching:
本辛加洞察已經編制了醫療保健行業的價值股清單,這些股票可能值得關注:
- Vicarious Surgical (NYSE:RBOT) - P/E: 6.22
- Walgreens Boots Alliance (NASDAQ:WBA) - P/E: 8.07
- Pfizer (NYSE:PFE) - P/E: 9.91
- Aadi Bioscience (NASDAQ:AADI) - P/E: 2.79
- Innoviva (NASDAQ:INVA) - P/E: 4.04
- 替代外科 (紐約證交所:方塊機器人)-P/E:6.22
- 沃爾格林靴子聯盟 (納斯達克:瓦巴)-P/E:8.07
- 輝瑞公司 (紐約證交所:全氟乙烯)-P/E: 9.91
- 阿迪生物科學 (納斯達克:阿迪)-P/E: 2.79
- 伊諾維娃 (納斯達克:因瓦)-P/E:4.04
Vicarious Surgical's earnings per share for Q3 sits at $-0.18, whereas in Q2, they were at -0.16. Most recently, Walgreens Boots Alliance reported earnings per share at $0.8, whereas in Q3 earnings per share sat at $0.96. Its most recent dividend yield is at 5.41%, which has increased by 0.35% from 5.06% in the previous quarter.
第三季度替代外科手術的每股收益為 -0.18 美元,而在第二季度則為 -0.16。最近,沃爾格林靴子聯盟報告了每股收益為 0.8 美元,而第三季度的每股收益為 0.96 美元。其最近期股息收益率為 5.41%,較上一季度的 5.06% 上升 0.35%。
Pfizer has reported Q3 earnings per share at $1.78, which has decreased by 12.75% compared to Q2, which was 2.04. Most recently, the company reported a dividend yield of 3.17%, which has decreased by 0.47% from last quarter's yield of 3.64%.
輝瑞公司報告第三季度的每股盈利為 1.78 美元,與第二季度相比下降了 12.75%,即 2.04 年第二季度。最近,該公司報告的股息收益率為 3.17%,較上一季度的 3.64% 的收益率下降了 0.47%。
Aadi Bioscience saw an increase in earnings per share from -0.69 in Q2 to $-0.68 now. Most recently, Innoviva reported earnings per share at $2.8, whereas in Q2 earnings per share sat at $0.05.
阿迪生物科學的每股收益從第二季度的 -0.69 增加到 -0.68 美元。最近,伊諾維娃報告了每股盈利為 2.8 美元,而第二季度每股盈利為 0.05 美元。
These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.
這 5 種價值股票是由 營運洞察 基於量化分析。儘管這種有條不紊的判斷過程並不意味著做出最終決定,但我們的技術可以為投資者提供額外的認知。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧